What's the most attractive weight-loss stock right now? We asked Seeking Alpha analysts Edmund Ingham, Stephen Ayers and Oneil Trader for their picks. Read more here.

Novo Nordisk (NVO) said its popular diabetes drug Ozempic, also known as semaglutide, has been approved to reduce the risk of kidney disease worsening, kidney failure, and death from cardiovascular ...

Many children born during Venezuela's crisis suffer from malnutrition. Father Jose Maria Gimeno has a mission - he wants to convert parents in Venezuela's slums to cheaper soy products instead of meat ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

A month’s supply of Ozempic is close to $1,000 without insurance ... have broad authority to enact tariffs and would be able to structure them as specifically as they wish.

From cabbage soup to the F-plan, quick fix diets promise everything from miracle weight loss to eternal youth – but do any of ...

A month’s supply of Ozempic is close to $1,000 without insurance ... The incoming administration will have broad authority to enact tariffs and would be able to structure them as specifically as they ...

Galderma chief executive Flemming Ørnskov said the use of Ozempic for weight loss was ... who want to look like they have better bone structure, for example men who want the appearance of a ...